Yvonne Martin
Yvonne Martin
Senior Volwiler Research Felllow, Abbott Laboratories (Retired) Volunteer, Neglected Diseases
Verified email at abbvie.com
Title
Cited by
Cited by
Year
A general and fast scoring function for protein− ligand interactions: a simplified potential approach
I Muegge, YC Martin
Journal of medicinal chemistry 42 (5), 791-804, 1999
11531999
QSAR modeling: where have you been? Where are you going to?
A Cherkasov, EN Muratov, D Fourches, A Varnek, II Baskin, M Cronin, ...
Journal of medicinal chemistry 57 (12), 4977-5010, 2014
8862014
Do structurally similar molecules have similar biological activity?
YC Martin, JL Kofron, LM Traphagen
Journal of medicinal chemistry 45 (19), 4350-4358, 2002
8322002
Use of structure− activity data to compare structure-based clustering methods and descriptors for use in compound selection
RD Brown, YC Martin
Journal of chemical information and computer sciences 36 (3), 572-584, 1996
7471996
Quantitative drug design: a critical introduction
YC Martin
CRC Press, 2010
7152010
3D QSAR in drug design: volume 1: theory methods and applications
H Kubinyi
Springer Science & Business Media, 1993
4851993
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists
YC Martin, MG Bures, EA Danaher, J DeLazzer, I Lico, PA Pavlik
Journal of computer-aided molecular design 7 (1), 83-102, 1993
4841993
The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding
RD Brown, YC Martin
Journal of Chemical Information and Computer Sciences 37 (1), 1-9, 1997
4391997
3D database searching in drug design
YC Martin
Journal of Medicinal Chemistry 35 (12), 2145-2154, 1992
3901992
A bioavailability score
YC Martin
Journal of medicinal chemistry 48 (9), 3164-3170, 2005
3062005
Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
MA Abreo, NH Lin, DS Garvey, DE Gunn, AM Hettinger, JT Wasicak, ...
Journal of medicinal chemistry 39 (4), 817-825, 1996
2841996
A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry
YC Martin
Journal of medicinal chemistry 24 (3), 229-237, 1981
2491981
ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional …
JH Van Drie, D Weininger, YC Martin
Journal of Computer-Aided Molecular Design 3 (3), 225-251, 1989
2381989
3D QSAR in drug design: recent advances
H Kubinyi, G Folkers, YC Martin
Springer Science & Business Media, 2006
1982006
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein
I Muegge, YC Martin, PJ Hajduk, SW Fesik
Journal of medicinal chemistry 42 (14), 2498-2503, 1999
1811999
Let’s not forget tautomers
YC Martin
Journal of computer-aided molecular design 23 (10), 693, 2009
1742009
Quantitative structure-activity relationships of drugs
J Topliss
Elsevier, 2012
1712012
Advances in Quantative Structure-Property Relationships
M Charton
Elsevier, 2002
162*2002
Designing combinatorial library mixtures using a genetic algorithm
RD Brown, YC Martin
Journal of medicinal chemistry 40 (15), 2304-2313, 1997
1441997
Application of belief theory to similarity data fusion for use in analog searching and lead hopping
SW Muchmore, DA Debe, JT Metz, SP Brown, YC Martin, PJ Hajduk
Journal of chemical information and modeling 48 (5), 941-948, 2008
1402008
The system can't perform the operation now. Try again later.
Articles 1–20